Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150

Benzinga · 1d ago
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.